Results 71 to 80 of about 7,256,584 (328)

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

open access: yesMolecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian   +10 more
wiley   +1 more source

Comparison of Renal Blood Flow Using Maximum Slope-Based Computed Tomography Perfusion and Ultrasound Flow Probe in Healthy Dogs

open access: yesFrontiers in Veterinary Science, 2020
Computed tomography (CT) perfusion can analyze tissue perfusion and quantitative parameters, including blood flow, blood volume, and transit time. CT perfusion has been used for evaluating split renal function.
Sang-Kwon Lee   +4 more
doaj   +1 more source

PENGARUH BERBAGAI DOSIS FILTRAT PARE (Momordicacharantia L) \ud TERHADAP KADAR GLUKOSA DARAH PADA TIKUS PUTIH (Rattus \ud norvegicus) HIPERGLIKEMIA [PDF]

open access: yes, 2008
Hyperglycemic is a condition that glucose content in blood increases from normal limitation. If this situation done in one year and continue, it will cause mellitus diabetes.
WARDHANI T.K, SETIA
core  

Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies

open access: yesMolecular Oncology, EarlyView.
We developed and validated a DNA methylation–based biomarker panel to distinguish pleural mesothelioma from other pleural conditions. Using the IMPRESS technology, we translated this panel into a clinically applicable assay. The resulting two classifier models demonstrated excellent performance, achieving high AUC values and strong diagnostic accuracy.
Janah Vandenhoeck   +12 more
wiley   +1 more source

Diagnostic value of blood culture growth patterns in distinguishing contaminants from pathogens

open access: yesJournal of Clinical Microbiology
Blood culture contamination is common, causing diagnostic uncertainty and unnecessary antibiotic use. Analyzing growth patterns within culture sets might offer diagnostic value. We retrospectively analyzed peripheral blood culture sets from 2019 and 2024.
Eli Ben-Chetrit   +2 more
doaj   +1 more source

Different faces of resistant hypertension in obesity

open access: yesArterial Hypertension, 2022
BACKGROUND: The aim was to conduct a comparative assessment between pseudo-resistant (due to different causes) and true resistant hypertension (RH) in obesity.
Anna Shalimova
doaj   +1 more source

A mathematical framework for combining decisions of multiple experts toward accurate and remote diagnosis of malaria using tele-microscopy. [PDF]

open access: yes, 2012
We propose a methodology for digitally fusing diagnostic decisions made by multiple medical experts in order to improve accuracy of diagnosis. Toward this goal, we report an experimental study involving nine experts, where each one was given more than 8 ...
Dimitrov, Stoyan   +6 more
core   +2 more sources

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

open access: yesMolecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad   +35 more
wiley   +1 more source

Variation in charges for 10 common blood tests in California hospitals: A cross-sectional analysis [PDF]

open access: yes, 2014
Objectives: To determine the variation in charges for 10 common blood tests across California hospitals in 2011, and to analyse the hospital and market-level factors that may explain any observed variation.
Akosa Antwi, Yaa   +2 more
core   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Home - About - Disclaimer - Privacy